Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex disparities matter in cancer development and therapy. | Nat Rev Cancer | 2021 | 33879867 | PubTator, text mining | PubMed |
| SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. | Cancer Res | 2021 | 33863777 | PubTator, text mining | PubMed |
| Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies. | Med | 2021 | 33860280 | PubTator, text mining | PubMed |
| TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia. | Blood Cancer Discov | 2021 | 33860275 | PubTator, text mining | PubMed |
| Mortality in children with positive SARS-CoV-2 polymerase chain reaction test: Lessons learned from a tertiary referral hospital in Indonesia. | Int J Infect Dis | 2021 | 33857609 | PubTator, text mining | PubMed |
| Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy. | Front Oncol | 2021 | 33854963 | PubTator, text mining | PubMed |
| Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. | Mol Med | 2021 | 33849427 | PubTator, text mining | PubMed |
| AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa. | Elife | 2021 | 33847261 | PubTator, text mining | PubMed |
| Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways. | Int J Oncol | 2021 | 33846781 | PubTator, text mining | PubMed |
| Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation. | Nat Commun | 2021 | 33846320 | PubTator, text mining | PubMed |
| Comparative Analysis of Global Proteome and Lysine Acetylome Between Naive CD4+ T Cells and CD4+ T Follicular Helper Cells. | Front Immunol | 2021 | 33841426 | PubTator, text mining | PubMed |
| The Oral Administration of Sanguisorba officinalis Extract Improves Physical Performance through LDHA Modulation. | Molecules | 2021 | 33809377 | PubTator, text mining | PubMed |
| The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells. | Cells | 2021 | 33808495 | PubTator, text mining | PubMed |
| SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer. | Pharmaceuticals (Basel) | 2021 | 33806675 | PubTator, text mining | PubMed |
| Remodeling of Cancer-Specific Metabolism under Hypoxia with Lactate Calcium Salt in Human Colorectal Cancer Cells. | Cancers (Basel) | 2021 | 33806179 | PubTator, text mining | PubMed |
| Quantitative Proteomic Approach Reveals Altered Metabolic Pathways in Response to the Inhibition of Lysine Deacetylases in A549 Cells under Normoxia and Hypoxia. | Int J Mol Sci | 2021 | 33806075 | PubTator, text mining | PubMed |
| The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis. | Cancers (Basel) | 2021 | 33804985 | PubTator, text mining | PubMed |
| Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer. | Cancers (Basel) | 2021 | 33804114 | PubTator, text mining | PubMed |
| Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma. | Int J Mol Sci | 2021 | 33802597 | PubTator, text mining | PubMed |
| Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers? | Brain Sci | 2021 | 33801069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=61